Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study

Autor: Bozhar, H, McKee, M, Spadea, T, Veerus, P, Heinävaara, S, Anttila, A, Senore, C, Zielonke, N, de Kok, IMCM, van Ravesteyn, NT, Lansdorp-Vogelaar, I, de Koning, HJ, Heijnsdijk, EAM, EU-TOPIA consortium

There are currently screening programmes for breast, cervical and colorectal cancer in many European countries. However, the uptake of cancer screening in general may vary within and between countries. The aim of this study is to assess the inequalit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::1a372b305d2813be71715d11dd857f43
https://researchonline.lshtm.ac.uk/id/eprint/4666324/7/Bozhar_etal_2022_Socio-economic-inequality-of-utilization.pdf

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing.

Autor: van Rosmalen, J, de Kok, IMCM, van Ballegooijen, M

Publikováno v: BJOG: An International Journal of Obstetrics & Gynaecology; May2012, Vol. 119 Issue 6, p699-709, 11p, 3 Charts, 1 Graph

State-level disparities in cervical cancer prevention and outcomes in the U.S.: a modeling study.

Autor: Alarid-Escudero F; Department of Health Policy, School of Medicine, and Stanford Health Policy, Freeman-Spogli Institute for International Studies, Stanford University, Stanford, CA, USA., Gracia V; Department of Health Policy, School of Medicine, Stanford University, Stanford, CA, USA., Wolf M; University of Minnesota Medical School, Minneapolis, MN, USA., Zhao R; Division of Epidemiology & Community Health, University of Minnesota School of Public Health, Minneapolis, MN, USA., Easterly CW; MD/PhD Program, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Carolina Population Center, Chapel Hill, NC., Kim JJ; Center for Health Decision Science, Department of Health Policy and Management, Harvard TH Chan School of Public Health, Boston, MA, USA., Canfell K; The Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW., de Kok IMCM; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands., Barnabas RV; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; School of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, T. H. Chan Harvard School of Public Health, Boston, MA, USA., Kulasingam S; Division of Epidemiology & Community Health, University of Minnesota School of Public Health, Minneapolis, MN, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.

Toward a Framework to Assess the Financial and Economic Burden of Cervical Cancer in Low- and Middle-Income Countries: A Systematic Review.

Autor: Fuady A; International Agency for Research on Cancer, (IARC/WHO), Early Detection, Prevention and Infections Branch, Lyon, France.; Department of Community Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.; Evidence-based Health Policy Center, Indonesian Medical Education and Research Institute, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia., Setiawan D; Faculty of Pharmacy, University of Muhammadiyah Purwokerto, Purwokerto, Indonesia., Man I; International Agency for Research on Cancer, (IARC/WHO), Early Detection, Prevention and Infections Branch, Lyon, France., de Kok IMCM; Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands., Baussano I; International Agency for Research on Cancer, (IARC/WHO), Early Detection, Prevention and Infections Branch, Lyon, France.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2024 Aug; Vol. 10, pp. e2400066.

The impact of loss to follow-up in the Dutch organised HPV-based cervical cancer screening programme.

Autor: Olthof EMG; Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands., Aitken CA; Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands., Siebers AG; Palga (The Dutch Nationwide Pathology Databank), Houten, The Netherlands., van Kemenade FJ; Department of Pathology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands., de Kok IMCM; Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.

Publikováno v: International journal of cancer [Int J Cancer] 2024 Jun 15; Vol. 154 (12), pp. 2132-2141. Date of Electronic Publication: 2024 Mar 04.